Dr. Dae-Won Kim, M.D., Ph.D., Associate Professor: Division of Cardiology, Daejeon St. Mary’s hospital, College of Medicine, The Catholic University of Korea, Dae-Jeon, Korea

Academic background :

Graduated in Chonbuk National University (2001.3-2007.2)

Acquisition of medical license (2007.3)

Internship in Catholic Medical Center (2007.3-2008.2)

Resident physician course in Catholic Medical Center (2008.3-2012.2)

Acquisition of internist license (2012.3)

Volunteered as KOICA (Korea International Cooperation Agency) international cooperation doctor in medical intensive care unit of the Siemreap Provincial Hospital (2012.4-2014.11)

Acquisition of Masters of Internal Medicine & graduate academic award (2015.8)

Certification of echocardiography by Korean Society of Echocardiography (2017.3.1)

TCTAP 2017 best abstract award (2017.4.26)

Certification of a subspecialty in charge of medicine (cardiology) (2017.10.15)

Certification of interventional cardiologist by Korean Society of Interventional Cardiology (2018.7)

Ph.D. in the Catholic University of Korea & graduate academic award (2018.8)

Young Investigator Award of 2018 from department of internal medicine in Catholic University (2019.3.9)

Korean Cardiac Research Foundation Research Fund : Clinical Effect through Simulation of Valvular Heart Disease using individualized 3-Dimensional Printing Model (2019.7)

National Research Foundation of Korea(NRF) grant funded by the Korea government (Ministry of Science and ICT)

(No. 2020R1G1A1099835) : Development of Artificial Intelligence-Deep learning based quantitative measuring process for coronary lesion in coronary CT angiography (2020.9.8)

Assistant professor (2020.3.1)

Associate professor (2024.3.1)

Academic funding for catholic scholarship (2021.3.9)

: Efficacy and safety of statin therapy for secondary prevention in patients with end stage renal disease and atherosclerotic cardiovascular disease through big data analysis

PI for proscpetive registry (2021.5) sponsored by Hanmi Pharmaceutical. :

A prospective, multicenter, randomized, open-label trial to compare efficacy and safety of moderate intensity atorvastatin versus moderate intensity rosuvastatin versus rosuvastatin plus ezetimibe on clinical outcome in ESRD patients with established atherosclerotic cardiovascular disease (The multicenter registry of end-stage renal Disease patiEnts with established atherosClerotic cardIovaScular dIsease to cOmpare cliNical outcomes according to STATIN therapy, (DECISION-STATIN Registry))

PI for RCT 1 year sponsored by Jeil Pharmaceutical Co., Ltd (2023.6.1)

: A Single center, Randomised, Open Placebo-controlled, Investigator initiated Clinical Trial to Assess the Efficacy and Safety of proton pump inhibitor in Patients with moderate bleeding risk and coronary artery disease undergoing percutaneous coronary intervention as compared with placebo

An advisor medicine at the Catholic Graduate School (2021.3.1)

Academic Research Fund for Holy Scholarship (2021.3.9)

: Effect of statin therapy on long-term mortality in dialysis patients with atherosclerotic cardiovascular diseases: A Population-Based Cohort Study

Catholic University of Medicine Research Foundation New Academic Research Fund (2021.11.1)

: Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A Population-Based Cohort Study

16th Academic Research Fund of the Korean Cardiovascular Arbitration Society

: Bio silk-printing based bioprosthetic heart valve development for a trial product

2022.12.3 K-CTO live demonstration 1^st operator

2023.6.10 :  2023 GICS (Gwangju International Interventional Cardiology Symposium)

Best oral competition award

2023.10.14 KSC (Korean Society of Cardiology) : case competition award (wire directed rendezvous technique cases in CTO PCI)

2024.1.19 : Editorial board member of Journal of Geriatric Medicine (ISSN ; 2630-5259) from 19 Jan. 2024 to 18 Jan. 2025

2024.7.18~7.28 : Evaluation Committee on the Selection of New Projects for Domestic Training after Doctor (Pharmaceutical, Korea Research Foundation)

2024.9.13~ : IRIS (Integrated R & D Information System) Pan-Ministry National R&D Project Evaluation Committee

2025.1.16~ : Editorial board member of Cardiovascular Research and Therapy.

2025.3.21: Domestic patent registration (methods and devices for analyzing blood vessels based on machine learning models)
Registration No. 10-2787021

2025.7.16-7.22 : Outstanding Emerging (Seed Research) Evaluation Committee Member (Korea Research Foundation 2025)

• Internal Medicine
• Cardiology
• Nephrology

• A Case of Hemicranial Pneumocephalus Secondary to Removal of a Central Venous Catheter. Korean Journal of Internal Medicine : 80 (2011) 2.first author IF 1.679
• Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. Metabolism clinical and experimental 62(2013) 952-960. 2013.1.7 published, first author, IF 3.096.
• Impact of postprocedural TIMI flow on long-term clinical outcomes in patients with acute myocardial infarction: 5 year Follow-Up Results in the Corea-AMI registry. International Heart Journal. 2017 Sep. 30, published, first author, IF 2.017.
• Clinical Implication According to Spasm Type of Single Coronary Artery provoked by Intracoronary Ergonovine Tests in Korean patients. International Journal of Cardiology 2018.2 published & first author, IF 6.189.
• The association of aortic regurgitation and cryptogenic embolic infarction with aortic complex plaque. International Journal of Stroke 2017. Jan 1 published first author, IF 3.314.
• Clinical implications of combined glucose intolerance in treatment-naïve hypertensive patients. 2018.1 published & first author, IF 1.162.
• Incremental Age-related 1-year MACCE after Acute Myocardial Infarction in the drug-eluting stent era (from KAMIR-NIH registry). Journal of Geriatric Cardiology 2018.Sep. 28 15:574-584 published first author IF 1.581 (SCIE).
• Association between Body Mass Index and 1-year outcome after Acute Myocardial Infarction. PLOS ONE 2019. Jun 14;14(6) published first author IF 2.776 (SCIE).
• Comparative Effectiveness Analysis of Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease and Unprotected Left Main Coronary Artery Disease : Insights From a Large-Sized All-Comers Registry. Eurointervention 2020. May 16(1);27-35 first author IF 4.018 (SCIE).
• Gender differences in clinical outcomes of acute myocardial infarction undergoing percutaneous coronary intervention : insights from the KAMIR-NIH registry. Journal of Geriatric Cardiology 2020.Dec. 17:680-693 published Corresponding author IF 2.491 (SCIE).
• Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction. PLOS ONE 2021.Oct.13 16 (10) published Corresponding author IF 3.240 (SCIE) ISSN 1932-6203.
• Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study. PLOS ONE 2023.Jun.2;18(6) published Corresponding author IF 3.752 (SCIE) ISSN 1932-6203.
• Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases. Scientific reports 2023.Jul 6;13 (1):10940 Corresponding author IF 4.996 (SCI) ISSN 2045-2322.
• Association between body mass index and three-year outcome of acute myocardial infarction. Scientific reports 2024.March 14:365 Corresponding author IF 4.996 (SCI) ISSN 2045-2322.

No content available to display!!!

No content available to display!!!